Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Yue

Showing results (301-310 of 355) with videos related to

Pageof 36
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 19, 2014
[Safety and effectiveness of tumor-ablative chemotherapy combined with low intensity modified conditioning regimen for 30 patients with hematologic malignancies receiving allogeneic hematopoietic stem cell transplantation]Rong-Mu Luo, Wan-ming Da, Bo Hu, et al.
World Journal of Gastrointestinal Oncology|May 2, 2019
Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian populationKa Wing Ma, Wong Hoi She, Albert Chi Yan Chan, et al.
Surgery Today|January 15, 2019
Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategyKa Wing Ma, Wong Hoi She, Tan To Cheung, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 17, 2018
Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched AnalysisKa Wing Ma, Kenneth Siu Ho Chok, Wong Hoi She, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2021
Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?Ka Wing Ma, Albert Chi Yan Chan, Kenneth Siu Ho Chok, et al.
Chemical & Pharmaceutical Bulletin|March 22, 2017
Design, Synthesis and Biological Evaluation of Potent Human Glyoxalase I InhibitorsTian Jin, Jing Zhai, Xiao Liu, et al.
Mikrochimica Acta|July 26, 2019
Gold nanoparticles anchored onto three-dimensional graphene: simultaneous voltammetric determination of dopamine and uric acidZhao Wang, Hong Yan Yue, Shuo Huang, et al.
Hepatology International|February 17, 2018
Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysisKa Wing Ma, Kenneth Siu Ho Chok, Wong Hoi She, et al.
International Journal of Surgery (London, England)|September 3, 2025
Single-cell RNA sequencing reveals immune regulatory mechanisms and molecular therapeutic strategies in the microenvironment of multiple myelomaQiang Su, Kehan Long, MoZiLi Adu, et al.
Hepatology (Baltimore, Md.)|October 18, 2008
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha geneChuan Yin, Yong Lin, Xin Zhang, et al.
Pageof 36

Showing results (301-310 of 355) with videos related to

Sort By:
Pageof 36
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 19, 2014
[Safety and effectiveness of tumor-ablative chemotherapy combined with low intensity modified conditioning regimen for 30 patients with hematologic malignancies receiving allogeneic hematopoietic stem cell transplantation]Rong-Mu Luo, Wan-ming Da, Bo Hu, et al.
World Journal of Gastrointestinal Oncology|May 2, 2019
Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian populationKa Wing Ma, Wong Hoi She, Albert Chi Yan Chan, et al.
Surgery Today|January 15, 2019
Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategyKa Wing Ma, Wong Hoi She, Tan To Cheung, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 17, 2018
Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched AnalysisKa Wing Ma, Kenneth Siu Ho Chok, Wong Hoi She, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2021
Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?Ka Wing Ma, Albert Chi Yan Chan, Kenneth Siu Ho Chok, et al.
Chemical & Pharmaceutical Bulletin|March 22, 2017
Design, Synthesis and Biological Evaluation of Potent Human Glyoxalase I InhibitorsTian Jin, Jing Zhai, Xiao Liu, et al.
Mikrochimica Acta|July 26, 2019
Gold nanoparticles anchored onto three-dimensional graphene: simultaneous voltammetric determination of dopamine and uric acidZhao Wang, Hong Yan Yue, Shuo Huang, et al.
Hepatology International|February 17, 2018
Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysisKa Wing Ma, Kenneth Siu Ho Chok, Wong Hoi She, et al.
International Journal of Surgery (London, England)|September 3, 2025
Single-cell RNA sequencing reveals immune regulatory mechanisms and molecular therapeutic strategies in the microenvironment of multiple myelomaQiang Su, Kehan Long, MoZiLi Adu, et al.
Hepatology (Baltimore, Md.)|October 18, 2008
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha geneChuan Yin, Yong Lin, Xin Zhang, et al.
Pageof 36